{
    "ticker": "PCRX",
    "name": "Pacira BioSciences, Inc.",
    "description": "Pacira BioSciences, Inc. is a leading pharmaceutical company dedicated to innovative solutions in post-surgical pain management. Founded in 2006 and headquartered in Parsippany, New Jersey, Pacira has developed a unique platform of products designed to improve the treatment of pain while minimizing the reliance on opioids. The company\u2019s flagship product, EXPAREL, is a long-acting local anesthetic that provides effective pain control while reducing the need for opioids in the postoperative setting. This innovative approach not only enhances patient recovery but also contributes to the ongoing efforts to combat the opioid crisis. Pacira continues to expand its product portfolio through research and development, focusing on delivering transformative products that address unmet medical needs in pain management and anesthesia. The company is also engaged in collaborations and partnerships to further advance its mission and bring new therapeutic options to market. With a commitment to improving patient outcomes and quality of life, Pacira is at the forefront of redefining pain management practices in healthcare.",
    "industry": [
        "Pharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Parsippany, New Jersey, USA",
    "founded": "2006",
    "website": "https://www.pacira.com",
    "ceo": "Dave Stack",
    "social_media": {
        "twitter": "https://twitter.com/pacira",
        "linkedin": "https://www.linkedin.com/company/pacira-biosciences/"
    },
    "investor_relations": "https://investors.pacira.com",
    "key_executives": [
        {
            "name": "Dave Stack",
            "position": "CEO"
        },
        {
            "name": "Jim Scibetta",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pain Management",
            "products": [
                "EXPAREL"
            ]
        },
        {
            "category": "Anesthesia Products",
            "products": [
                "Bupivacaine Liposome Injectable Suspension"
            ]
        }
    ],
    "seo": {
        "meta_title": "Pacira BioSciences, Inc. | Innovative Pain Management Solutions",
        "meta_description": "Explore Pacira BioSciences, Inc., a leader in post-surgical pain management with innovative products like EXPAREL that reduce opioid use and enhance recovery.",
        "keywords": [
            "Pacira",
            "EXPAREL",
            "Pain Management",
            "Opioid Crisis",
            "Surgical Pain Relief",
            "Healthcare Innovations"
        ]
    },
    "faq": [
        {
            "question": "What is Pacira known for?",
            "answer": "Pacira is known for its innovative pain management solutions, particularly the long-acting local anesthetic EXPAREL."
        },
        {
            "question": "Who is the CEO of Pacira?",
            "answer": "Dave Stack is the CEO of Pacira BioSciences, Inc."
        },
        {
            "question": "Where is Pacira headquartered?",
            "answer": "Pacira is headquartered in Parsippany, New Jersey, USA."
        },
        {
            "question": "What are Pacira's main products?",
            "answer": "Pacira's main product is EXPAREL, a long-acting local anesthetic used for post-surgical pain management."
        },
        {
            "question": "When was Pacira founded?",
            "answer": "Pacira was founded in 2006."
        }
    ],
    "competitors": [
        "PFE",
        "JNJ",
        "ABBV",
        "VRX"
    ],
    "related_stocks": [
        "AMGN",
        "REGN",
        "GILD",
        "BMY"
    ]
}